Stefan Nickels is Director of Global Internal Audit at Daiichi Sankyo, where he works at the intersection of governance, digital transformation, and regulated life sciences operations. With 15+ years of experience across Internal Audit, investigations, and risk, he is known for translating complex topics such as AI governance, data integrity, third-party ecosystems, and digital operating risk into decision-relevant insight for senior leadership and Audit Committees. His work focuses on a simple question: when innovation scales, is the operating model underneath it robust enough to carry the ambition? Stefan is particularly interested in the point where AI adoption, data flows, and vendor dependencies outpace governance and where success itself can expose structural weaknesses if accountability, evidence, and operating reality do not keep up.
As agentic AI moves from demos to decisions, pharma leaders must decide what to build, what to buy, and where partnership creates advantage. This panel cuts through hype to debate ownership, governance, validation, and the real sources of competitive moat.